ElectroCore, Inc. Appoints Sylvester Steele as VP and General Manager of Government Channels Business Unit
October 21, 2020 at 08:00 am EDT
Share
electroCore, Inc. announced the appointment of Sylvester “Sly” Steele to the newly created position of Vice President and General Manager of the Government Channels Business Unit. Mr. Steele brings to electroCore extensive leadership experience, including more than 20 years in the U.S. Navy leading organizations and developing complex systems. In his role, Mr. Steele will be responsible for driving growth of gammaCore Sapphire non-invasive vagus nerve stimulation therapy (nVNS) within the Veterans Administration (VA) and Department of Defense (DoD), as well as developing new revenue opportunities within government channels. Prior to joining electroCore, Mr. Steele served as the Senior Director of Business Development and Sales at Juul Labs, Inc., a private U.S. electronic cigarette company. At Juul Labs, he established the company’s first integrated vertical sales unit focused on the defense and veteran retail segment and developed rapid sales growth within military retail chains. Prior to Juul Labs, Mr. Steele served with distinction for two decades in the U.S. Navy. He served in a variety of leadership roles, including as Commanding Officer (Chief Executive Officer) of two warships (USS Stout, USS The Sullivans) and as a senior advisor and strategy leader at U.S. Fleet Forces Command and Naval Special Warfare Development Group. Mr. Steele earned his B.S. in Electrical Engineering from the United States Naval Academy, his M.S. in Industrial Management from the University of Arkansas, and his M.A. in National Security and Strategic Studies from the U.S. Naval War College.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Companyâs product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Companyâs TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.